PLK1 and neoplasm: The clinical study in non-small cell lung cancer patients showed that PLK1’s high expression was markedly associated with advanced clinical stage, higher tumor classification, and lymph node metastasis, and was an independent unfavorable prognostic biomarker for non-small cell lung cancer patients [15].